Targeted Drug Delivery Systems for Lung Cancer

  • Posted on: 1 February 2015
  • By: admin

 

Magazine Home


FEB 2015 ARTICLE LIST >>

PharmaTutor (February- 2015)

 

Print-ISSN: 2394 - 6679
e-ISSN: 2347 - 7881
(Volume 3, Issue 2)

 

Received On: 05/11/2014; Accepted On: 14/12/2014; Published On: 01/02/2015

 

AUTHORS: Abdul Waheed1*, Ankit Gupta2, Parth Patel3
1Department of Pharmacology
2Department of Pharmaceutics
3Department of Drug Regulatory Affair
Amity Institute of Pharmacy, Amity University, Noida-125, U.P. (INDIA)
abdul.waheed2050@gmail.com

 

ABSTRACT: In the present scenario, lung cancer is one of the most prevalent and malignant cancer especially among the smoking group of people. The targeted delivery of chemotherapeutic agents to the lungs represents a novel therapeutic approach in lung cancer. Lung is an ideal route for administration of anticancer drug as it provides larger alveolar surface area, low thickness of epithelial barrier & extensive vascularization. Nanoparticles with nanocarriers have possibility of cell-targeted drug delivery with minimal systemic side effect and toxicity. Pulmonary epithelial cell, enzymes, receptors and genes are the target of the targeted drug delivery in lung cancer. This paper reviews the till date targeted drug delivery research performed for the treatment of lung cancer.

 

How to cite this article: A Waheed, A Gupta, P Patel; Targeted Drug Delivery Systems for Lung Cancer; PharmaTutor; 2015; 3(2); 38-42

 

[ABSTRACT WITH CITATION]   [VIEW AS HTML]